These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3154682

  • 1. Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients.
    Lehtonen A.
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):549-51. PubMed ID: 3154682
    [Abstract] [Full Text] [Related]

  • 2. Long-term effect of pindolol on plasma lipids, apoproteins A, blood glucose, and serum insulin levels.
    Lehtonen A.
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):269-72. PubMed ID: 6430812
    [Abstract] [Full Text] [Related]

  • 3. The effects of trimazosin and pindolol on serum lipids, blood glucose and serum insulin levels.
    Lehtonen A.
    Acta Med Scand; 1985 May; 218(2):213-6. PubMed ID: 3904336
    [Abstract] [Full Text] [Related]

  • 4. Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
    Pesant Y, Marc-Aurèle J, Bielmann P, Alaupovic P, Cartier P, Bichet D, Thibault G, Lupien PJ.
    Am J Ther; 1999 May; 6(3):137-47. PubMed ID: 10423656
    [Abstract] [Full Text] [Related]

  • 5. Effect of pindolol versus atenolol on lipid profile in hypertensive patients.
    Notghi A, Riemersma RA, Anderton JL, Oliver MF.
    Atherosclerosis; 1989 Jun; 77(2-3):215-20. PubMed ID: 2751753
    [Abstract] [Full Text] [Related]

  • 6. Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
    Fogari R, Zoppi A, Malamani GD, Marasi G, Vanasia A, Villa G.
    Br J Clin Pharmacol; 1995 May; 39(5):471-6. PubMed ID: 7669481
    [Abstract] [Full Text] [Related]

  • 7. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T, Lehtonen A.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [Abstract] [Full Text] [Related]

  • 8. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
    Sasaki J, Saku K, Ideishi M, Arakawa K, Kato Y, Kuwano E, So T.
    Clin Ther; 1989 Jun; 11(2):219-24. PubMed ID: 2736568
    [Abstract] [Full Text] [Related]

  • 9. Effects of pindolol on serum lipoproteins and postheparin lipolytic activities in hypertensive patients.
    Sasaki N, Saito Y, Shinomiya M, Kanzaki T, Ishikawa Y, Mori S, Kobayashi J, Murano S, Nishide T, Morisaki N.
    Clin Ther; 1990 Jun; 12(2):157-64. PubMed ID: 2354485
    [Abstract] [Full Text] [Related]

  • 10. Effect of beta-blockers on plasma lipids.
    Pasotti C, Zoppi A, Capra A, Rebagliati M, Fogari R.
    Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):448-52. PubMed ID: 3759280
    [Abstract] [Full Text] [Related]

  • 11. Long-term effect of pindolol on lipids and lipoproteins in men with newly diagnosed hypertension.
    Terént A, Ribacke M, Carlson LA.
    Eur J Clin Pharmacol; 1989 Aug; 36(4):347-50. PubMed ID: 2737226
    [Abstract] [Full Text] [Related]

  • 12. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
    Lehtonen A, Himanen P, Saraste M, Niittymäki K, Marniemi J.
    Br J Clin Pharmacol; 1986 Aug; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
    [Abstract] [Full Text] [Related]

  • 13. Metabolic effects of a change in antihypertensive treatment.
    Lithell H, Aberg H, Selinus I.
    Am J Med; 1986 Feb 14; 80(2A):114-9. PubMed ID: 3511690
    [Abstract] [Full Text] [Related]

  • 14. Lipoprotein lipids and apoproteins during beta-blocker administration: comparison of penbutolol and atenolol.
    Välimäki M, Maass L, Harno K, Nikkilä EA.
    Eur J Clin Pharmacol; 1986 Feb 14; 30(1):17-20. PubMed ID: 3709628
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the hypotensive and metabolic effects of 50 and 100 mg atenolol per day.
    Lithell H, Aberg H, Selinus I.
    Drugs Exp Clin Res; 1986 Feb 14; 12(5):393-6. PubMed ID: 3720523
    [Abstract] [Full Text] [Related]

  • 16. [Comparative effects of pindolol and atenolol on blood pressure and lipids in mild to moderate arterial hypertension].
    Herpin D, Guillard O, Piriou A, Amiel A, Boutaud P, Ciber MA, Demange J.
    Ann Med Interne (Paris); 1988 Feb 14; 139(7):484-7. PubMed ID: 3072894
    [Abstract] [Full Text] [Related]

  • 17. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Cardiovasc Pharmacol; 1982 Feb 14; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [Abstract] [Full Text] [Related]

  • 18. [Effects of terazosine and atenolol on serum lipids in essential hypertension].
    Bur A, Woisetschläger C, Herkner H, Derhaschnig U, Quehenberger P, Hirschl MM.
    Z Kardiol; 2002 Sep 14; 91(9):685-92. PubMed ID: 12448067
    [Abstract] [Full Text] [Related]

  • 19. Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol.
    England JD.
    Aust N Z J Med; 1981 Feb 14; 11(1):35-40. PubMed ID: 7018482
    [Abstract] [Full Text] [Related]

  • 20. Effects of pindolol and clopamide on blood lipids in arterial hypertensive patients.
    Román O, Pino ME, Valenzuela A.
    Cardiology; 1987 Feb 14; 74(3):219-25. PubMed ID: 3594511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.